In this study, 501 out of 1,051 individuals with MHO at baseline (48%) developed metabolic syndrome over a median follow-up of 12.2 years. Moreover, they then had increased odds of CVD (odds ratio, 1.60; 95% confidence interval, 1.14-2.25), compared with individuals who had stable MHO or normal weight.
Duration of metabolic syndrome was linearly associated with CVD risk, with an odds ratio of 0.41 for those with metabolic syndrome at one out of five study visits, 2.19 for metabolic syndrome at two or three visits, and 2.50 for metabolic syndrome at four or five visits, the researchers said.
The results of this study may explain why some previous meta-analyses found individuals with MHO had increased risk, but only with longer duration of follow-up.
“Both transition to metabolic syndrome and longer duration of metabolic syndrome were associated with CVD, indicating that those with MHO may experience a lag in risk while they progress to metabolic syndrome and develop the resultant cardiometabolic risk,” Dr. Mongraw-Chaffin and her coauthors wrote.